Overview
- 106 inspections across 93 sites are on record.
- 436 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-02-25.
At a glance
Inspections
106
Sites
93
Observations
436
Career since
Sep 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cardinal Health 414, Inc. | 25 Feb 2020 | Human Drugs | View 483 → |
| SEAGEN INC. | 24 Jan 2020 | Human Drugs | |
| Strohecker's Pharmacy | 27 Nov 2019 | Human Drugs | On file |
| Bakelite Chemicals LLC | 20 Nov 2019 | Animal Drugs & Feeds | View 483 → |
| Asclemed USA Inc. dba Enovachem | 5 Nov 2019 | Human Drugs |
Sites inspected
Cardinal Health 414, Inc.Seattle, United States1 insp.
SEAGEN INC.Bothell, United States1 insp.
Strohecker's PharmacyPortland, United States1 insp.
Bakelite Chemicals LLCAlbany, United States1 insp.
Asclemed USA Inc. dba EnovachemTorrance, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Robert D Tollefsen7 shared
Sunitha K Rajaram7 shared
Marijo B Kambere6 shared
Christopher R Czajka6 shared
Heika R Tait6 shared
Tracy K Li4 shared
Lori J Silverstein4 shared
Kenneth O Gee3 shared
Jose A Lopez Rubet3 shared
Dirk L Lincoln3 shared
Full investigator report
Get the verbatim findings behind Anita Narula's 436 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site